| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 2.28e-08 | 37 | 169 | 7 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 2.78e-08 | 38 | 169 | 7 | GO:0070001 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 7.42e-07 | 38 | 169 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 1.56e-06 | 11 | 169 | 4 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 4.64e-06 | 14 | 169 | 4 | GO:0003964 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 5.88e-06 | 5 | 169 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.65e-05 | 21 | 169 | 4 | GO:0035613 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 GRM3 GRM7 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B TAS1R2 OR1E3 TAS2R40 HCRTR1 | 6.09e-05 | 884 | 169 | 20 | GO:0004930 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERVK-6 SETX POLD1 RECQL ERVK-7 ERVK-10 REV3L FANCM ERVK-8 DNASE2 | 8.18e-05 | 262 | 169 | 10 | GO:0140097 |
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 9.35e-05 | 11 | 169 | 3 | GO:0015217 | |
| GeneOntologyMolecularFunction | catecholamine binding | 1.60e-04 | 13 | 169 | 3 | GO:1901338 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 GRM3 GRM7 ABCA7 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B PTPRB PTPRM TAS1R2 OR1E3 ROBO1 TAS2R40 IL1R1 HCRTR1 | 1.85e-04 | 1353 | 169 | 25 | GO:0004888 |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 2.02e-04 | 14 | 169 | 3 | GO:0005347 | |
| GeneOntologyMolecularFunction | alpha2-adrenergic receptor activity | 2.12e-04 | 3 | 169 | 2 | GO:0004938 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 2.63e-04 | 37 | 169 | 4 | GO:0016891 | |
| GeneOntologyMolecularFunction | endopeptidase activity | ERVK-6 CASP2 C1RL ERVK-7 ERVK-10 ERVK-8 TMPRSS2 PAPPA ERVK-19 ERVK-25 SPRTN ERVK-24 | 3.09e-04 | 430 | 169 | 12 | GO:0004175 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 3.18e-04 | 152 | 169 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | G protein-coupled amine receptor activity | 3.93e-04 | 41 | 169 | 4 | GO:0008227 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.43e-04 | 18 | 169 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 5.07e-04 | 118 | 169 | 6 | GO:0003774 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6.12e-04 | 46 | 169 | 4 | GO:0016893 | |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 7.00e-04 | 5 | 169 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 7.00e-04 | 5 | 169 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 9.31e-04 | 23 | 169 | 3 | GO:0005346 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC25A4 SLC25A5 SLC25A6 SLC35E1 SLC1A6 SLC5A2 SLC5A11 SLC7A8 SLC8B1 | 9.67e-04 | 296 | 169 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | epinephrine binding | 1.04e-03 | 6 | 169 | 2 | GO:0051379 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 1.04e-03 | 6 | 169 | 2 | GO:0004936 | |
| GeneOntologyMolecularFunction | four-way junction helicase activity | 1.04e-03 | 6 | 169 | 2 | GO:0009378 | |
| GeneOntologyMolecularFunction | antiporter activity | 1.15e-03 | 138 | 169 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.34e-03 | 26 | 169 | 3 | GO:0000295 | |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 NAALAD2 CASP2 C1RL ERVK-7 CPM ERVK-10 ERVK-8 TMPRSS2 PAPPA ERVK-19 ERVK-25 SPRTN ERVK-24 | 1.37e-03 | 654 | 169 | 14 | GO:0008233 |
| GeneOntologyMolecularFunction | D-glucose:sodium symporter activity | 1.45e-03 | 7 | 169 | 2 | GO:0005412 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 1.57e-03 | 59 | 169 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.67e-03 | 28 | 169 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 1.85e-03 | 29 | 169 | 3 | GO:0015216 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH7 SETX DDX31 RECQL UBA3 FANCM ABCA7 DNAH1 ATP11B MYO3B DNAH17 KIF5A DNAH9 | 2.23e-03 | 614 | 169 | 13 | GO:0140657 |
| GeneOntologyMolecularFunction | G protein-coupled glutamate receptor activity | 2.47e-03 | 9 | 169 | 2 | GO:0098988 | |
| GeneOntologyMolecularFunction | heterotrimeric G-protein binding | 2.47e-03 | 9 | 169 | 2 | GO:0032795 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 2.47e-03 | 9 | 169 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | adenylate cyclase inhibiting G protein-coupled glutamate receptor activity | 2.47e-03 | 9 | 169 | 2 | GO:0001640 | |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 2.70e-03 | 33 | 169 | 3 | GO:0015215 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 2.94e-03 | 70 | 169 | 4 | GO:0003777 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 3.06e-03 | 10 | 169 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 3.06e-03 | 10 | 169 | 2 | GO:0004935 | |
| GeneOntologyMolecularFunction | nuclease activity | 3.59e-03 | 231 | 169 | 7 | GO:0004518 | |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 3.72e-03 | 11 | 169 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.75e-03 | 37 | 169 | 3 | GO:0045505 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.32e-07 | 48 | 171 | 7 | GO:0000731 | |
| GeneOntologyBiologicalProcess | regulation of system process | MYH7 DRD2 GALR1 HTR2A SLC25A4 NTSR1 NMUR2 CMYA5 GRM3 STC1 JAM2 ADORA2B ADRA2A ADRA2B TENM4 CELF2 NFATC1 FDPS LPCAT3 WDR35 CCL3 CACNA1H | 1.94e-07 | 734 | 171 | 22 | GO:0044057 |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 DSC1 PCDHGC5 NRCAM PCDHGB1 PCDHGA11 PCDHB13 PCDHB8 SLITRK2 TENM4 HMCN1 PTPRM SLITRK5 ROBO1 | 3.68e-07 | 313 | 171 | 14 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 DSC1 PCDHGC5 NRCAM PCDHGB1 PCDHGA11 PCDHB13 PCDHB8 HMCN1 PTPRM ROBO1 | 4.75e-07 | 187 | 171 | 11 | GO:0007156 |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | ERVK-6 HTR2A ATR POLD1 ERVK-7 SMG5 ERVK-10 REV3L NFATC1 ERVK-8 SPRTN | 2.15e-06 | 218 | 171 | 11 | GO:0071897 |
| GeneOntologyBiologicalProcess | DNA integration | 3.08e-06 | 13 | 171 | 4 | GO:0015074 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 5.53e-06 | 5 | 171 | 3 | GO:0140021 | |
| GeneOntologyBiologicalProcess | muscle system process | MYH7 DRD2 HTR1D HTR2A SLC25A4 NMUR2 CMYA5 STC1 ADORA2B ADRA2A ADRA2B NFATC1 FDPS PLA2G6 CACNA1H ASB2 | 1.35e-05 | 547 | 171 | 16 | GO:0003012 |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.54e-05 | 133 | 171 | 8 | GO:0006939 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.82e-05 | 178 | 171 | 9 | GO:0006261 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 3.04e-05 | 8 | 171 | 3 | GO:1990544 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 6.62e-05 | 83 | 171 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | regulation of muscle system process | MYH7 SLC25A4 NMUR2 CMYA5 STC1 ADORA2B ADRA2A ADRA2B NFATC1 FDPS CACNA1H | 7.08e-05 | 317 | 171 | 11 | GO:0090257 |
| GeneOntologyBiologicalProcess | regulation of amine transport | 8.35e-05 | 125 | 171 | 7 | GO:0051952 | |
| GeneOntologyBiologicalProcess | ADP transport | 1.17e-04 | 12 | 171 | 3 | GO:0015866 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transport | 1.18e-04 | 92 | 171 | 6 | GO:0051926 | |
| GeneOntologyBiologicalProcess | skeletal muscle adaptation | 1.37e-04 | 32 | 171 | 4 | GO:0043501 | |
| GeneOntologyBiologicalProcess | amine transport | 1.48e-04 | 137 | 171 | 7 | GO:0015837 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, glutamatergic | 1.51e-04 | 13 | 171 | 3 | GO:0051967 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion import | 1.74e-04 | 34 | 171 | 4 | GO:0090280 | |
| GeneOntologyBiologicalProcess | arachidonate secretion | 2.18e-04 | 36 | 171 | 4 | GO:0050482 | |
| GeneOntologyBiologicalProcess | arachidonate transport | 2.18e-04 | 36 | 171 | 4 | GO:1903963 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 2.36e-04 | 67 | 171 | 5 | GO:0099171 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 2.36e-04 | 67 | 171 | 5 | GO:0050433 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.37e-04 | 15 | 171 | 3 | GO:1901029 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DCHS2 HTR2A DSC1 PCDHGC5 NRCAM PCDHGB1 PCDHGA11 PCDHB13 PCDHB8 NFASC FCHO1 JAM2 HHLA2 SLITRK2 PBRM1 TENM4 HMCN1 PTPRM SLITRK5 ROBO1 FUT7 | 2.38e-04 | 1077 | 171 | 21 | GO:0098609 |
| GeneOntologyBiologicalProcess | sensory perception of pain | 2.43e-04 | 105 | 171 | 6 | GO:0019233 | |
| GeneOntologyBiologicalProcess | sensory perception of temperature stimulus | 2.70e-04 | 38 | 171 | 4 | GO:0050951 | |
| GeneOntologyBiologicalProcess | negative regulation of calcium ion transmembrane transport | 2.70e-04 | 69 | 171 | 5 | GO:1903170 | |
| GeneOntologyBiologicalProcess | DNA replication | ERVK-6 ATR POLD1 RECQL ERVK-7 ERVK-10 REV3L FANCM ADRA2A ERVK-8 | 2.87e-04 | 312 | 171 | 10 | GO:0006260 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 2.90e-04 | 202 | 171 | 8 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 2.90e-04 | 202 | 171 | 8 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 3.00e-04 | 203 | 171 | 8 | GO:0035150 | |
| GeneOntologyBiologicalProcess | calcium ion transport | DRD2 HTR2A NTSR1 STC1 CUL5 ADRA2A SLC8B1 PPP3CB MS4A1 NFATC1 UBR3 CCL3 CACNA1H | 3.36e-04 | 509 | 171 | 13 | GO:0006816 |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 3.44e-04 | 112 | 171 | 6 | GO:0019226 | |
| GeneOntologyBiologicalProcess | receptor transactivation | 4.06e-04 | 4 | 171 | 2 | GO:0035624 | |
| GeneOntologyBiologicalProcess | negative regulation of adenylate cyclase activity | 4.17e-04 | 18 | 171 | 3 | GO:0007194 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 4.17e-04 | 18 | 171 | 3 | GO:0006999 | |
| GeneOntologyBiologicalProcess | negative regulation of amine transport | 4.37e-04 | 43 | 171 | 4 | GO:0051953 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | DRD2 HTR2A NTSR1 CUL5 ADRA2A SLC8B1 PPP3CB MS4A1 UBR3 CCL3 CACNA1H | 4.45e-04 | 392 | 171 | 11 | GO:0070588 |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.68e-04 | 217 | 171 | 8 | GO:0097553 | |
| GeneOntologyBiologicalProcess | negative regulation of cyclase activity | 4.92e-04 | 19 | 171 | 3 | GO:0031280 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 5.07e-04 | 79 | 171 | 5 | GO:0050432 | |
| GeneOntologyBiologicalProcess | muscle contraction | MYH7 DRD2 HTR1D HTR2A NMUR2 STC1 ADORA2B ADRA2A ADRA2B PLA2G6 CACNA1H | 5.26e-04 | 400 | 171 | 11 | GO:0006936 |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 GRM3 GRM7 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B ATRNL1 TAS1R2 OR1E3 ROBO1 CCL3 C3 TAS2R40 HCRTR1 | 5.29e-04 | 1395 | 171 | 24 | GO:0007186 |
| GeneOntologyBiologicalProcess | negative regulation of monoatomic ion transport | 5.71e-04 | 171 | 171 | 7 | GO:0043271 | |
| GeneOntologyBiologicalProcess | regulation of skeletal muscle adaptation | 5.75e-04 | 20 | 171 | 3 | GO:0014733 | |
| GeneOntologyBiologicalProcess | sensory perception | HEXA DRD2 HTR2A EPYC NTSR1 NMUR2 LXN GRM3 GRM7 OR10R2 OR5J2 ADRA2A HMCN1 SEMA5B MYO3B TAS1R2 OR1E3 UBR3 CCL3 TAS2R40 | 5.90e-04 | 1072 | 171 | 20 | GO:0007600 |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 6.58e-04 | 286 | 171 | 9 | GO:0007188 | |
| GeneOntologyBiologicalProcess | protein localization to paranode region of axon | 6.72e-04 | 5 | 171 | 2 | GO:0002175 | |
| GeneOntologyBiologicalProcess | protein localization to juxtaparanode region of axon | 6.72e-04 | 5 | 171 | 2 | GO:0071205 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 7.10e-04 | 85 | 171 | 5 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 7.10e-04 | 85 | 171 | 5 | GO:0000768 | |
| GeneOntologyBiologicalProcess | positive regulation of lipid localization | 7.30e-04 | 129 | 171 | 6 | GO:1905954 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway | 7.48e-04 | 86 | 171 | 5 | GO:0007193 | |
| GeneOntologyBiologicalProcess | negative regulation of lyase activity | 7.68e-04 | 22 | 171 | 3 | GO:0051350 | |
| GeneOntologyBiologicalProcess | syncytium formation | 8.74e-04 | 89 | 171 | 5 | GO:0006949 | |
| GeneOntologyBiologicalProcess | renal tubular secretion | 8.78e-04 | 23 | 171 | 3 | GO:0097254 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 8.78e-04 | 23 | 171 | 3 | GO:0035795 | |
| GeneOntologyBiologicalProcess | regulation of sensory perception of pain | 8.78e-04 | 23 | 171 | 3 | GO:0051930 | |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 8.78e-04 | 23 | 171 | 3 | GO:0033604 | |
| GeneOntologyBiologicalProcess | ATP transport | 8.78e-04 | 23 | 171 | 3 | GO:0015867 | |
| GeneOntologyBiologicalProcess | axonogenesis | DRD2 NRCAM CNTNAP1 NFASC SEMA3D SLITRK2 PPP3CB PTPRM SEMA5B DOCK7 SLITRK5 ROBO1 KIF5A | 9.04e-04 | 566 | 171 | 13 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | DRD2 NRCAM CNTNAP1 NFASC GRM7 SEMA3D SLITRK2 PPP3CB PTPRM SEMA5B DOCK7 SLITRK5 ROBO1 KIF5A | 9.51e-04 | 642 | 171 | 14 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 9.97e-04 | 24 | 171 | 3 | GO:1901028 | |
| GeneOntologyBiologicalProcess | regulation of sensory perception | 9.97e-04 | 24 | 171 | 3 | GO:0051931 | |
| GeneOntologyBiologicalProcess | grooming behavior | 9.97e-04 | 24 | 171 | 3 | GO:0007625 | |
| GeneOntologyBiologicalProcess | adenine transport | 1.00e-03 | 6 | 171 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, glutamatergic | 1.02e-03 | 92 | 171 | 5 | GO:0051966 | |
| GeneOntologyBiologicalProcess | DNA repair | ERVK-6 SETX ATR POLD1 RECQL ERVK-7 ERVK-10 REV3L FANCM PBRM1 PPP5C PAXIP1 ERVK-8 SPRTN | 1.04e-03 | 648 | 171 | 14 | GO:0006281 |
| GeneOntologyBiologicalProcess | blood circulation | MYH7 DRD2 HTR1D HTR2A NTSR1 STC1 ADORA2B ADRA2A ADRA2B CELF2 PTPRM WDR35 PLA2G6 CACNA1H | 1.04e-03 | 648 | 171 | 14 | GO:0008015 |
| GeneOntologyCellularComponent | postsynaptic membrane | DRD2 HTR2A NRCAM PCDHB13 PCDHB8 CSMD2 GRM3 GRM7 SLC1A6 ADRA2A SLITRK2 SLITRK5 CACNA1H | 3.86e-05 | 405 | 175 | 13 | GO:0045211 |
| GeneOntologyCellularComponent | septate junction | 6.97e-05 | 2 | 175 | 2 | GO:0005918 | |
| Domain | 7TM_GPCR_Srsx | GPR12 DRD2 HTR1D GALR1 HTR2A NMUR2 ADORA2B ADRA2A ADRA2B HCRTR1 | 4.83e-08 | 112 | 162 | 10 | SM01381 |
| Domain | Cadherin_C | 3.03e-05 | 42 | 162 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 3.03e-05 | 42 | 162 | 5 | PF16492 | |
| Domain | Cadherin_CS | 4.61e-05 | 109 | 162 | 7 | IPR020894 | |
| Domain | CADHERIN_1 | 5.80e-05 | 113 | 162 | 7 | PS00232 | |
| Domain | Cadherin | 5.80e-05 | 113 | 162 | 7 | PF00028 | |
| Domain | CADHERIN_2 | 6.13e-05 | 114 | 162 | 7 | PS50268 | |
| Domain | - | 6.13e-05 | 114 | 162 | 7 | 2.60.40.60 | |
| Domain | CA | 6.48e-05 | 115 | 162 | 7 | SM00112 | |
| Domain | Cadherin-like | 6.85e-05 | 116 | 162 | 7 | IPR015919 | |
| Domain | Znf-C4pol | 7.48e-05 | 2 | 162 | 2 | IPR025687 | |
| Domain | zf-C4pol | 7.48e-05 | 2 | 162 | 2 | PF14260 | |
| Domain | Cadherin | 7.64e-05 | 118 | 162 | 7 | IPR002126 | |
| Domain | Mit_uncoupling | 1.33e-04 | 12 | 162 | 3 | IPR002030 | |
| Domain | NCD3G | 1.72e-04 | 13 | 162 | 3 | PF07562 | |
| Domain | GPCR_3_9-Cys_dom | 1.72e-04 | 13 | 162 | 3 | IPR011500 | |
| Domain | GPCR_3_CS | 2.17e-04 | 14 | 162 | 3 | IPR017979 | |
| Domain | - | 2.23e-04 | 3 | 162 | 2 | 3.90.1600.10 | |
| Domain | DNA_pol_palm_dom | 2.23e-04 | 3 | 162 | 2 | IPR023211 | |
| Domain | DNA_POLYMERASE_B | 2.23e-04 | 3 | 162 | 2 | PS00116 | |
| Domain | G2F | 2.23e-04 | 3 | 162 | 2 | SM00682 | |
| Domain | DNA-dir_DNA_pol_B_CS | 2.23e-04 | 3 | 162 | 2 | IPR017964 | |
| Domain | Cadherin_2 | 2.51e-04 | 65 | 162 | 5 | PF08266 | |
| Domain | Cadherin_N | 2.51e-04 | 65 | 162 | 5 | IPR013164 | |
| Domain | LamGL | 4.44e-04 | 4 | 162 | 2 | SM00560 | |
| Domain | Neurofascin/L1/NrCAM_C | 4.44e-04 | 4 | 162 | 2 | IPR026966 | |
| Domain | G2F | 4.44e-04 | 4 | 162 | 2 | PF07474 | |
| Domain | LamG-like | 4.44e-04 | 4 | 162 | 2 | IPR006558 | |
| Domain | DNA_pol_B | 4.44e-04 | 4 | 162 | 2 | PF00136 | |
| Domain | NIDOGEN_G2 | 4.44e-04 | 4 | 162 | 2 | PS50993 | |
| Domain | GFP | 4.44e-04 | 4 | 162 | 2 | IPR009017 | |
| Domain | Bravo_FIGEY | 4.44e-04 | 4 | 162 | 2 | PF13882 | |
| Domain | DNA-dir_DNA_pol_B | 4.44e-04 | 4 | 162 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 4.44e-04 | 4 | 162 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 4.44e-04 | 4 | 162 | 2 | IPR006134 | |
| Domain | DNA_pol_B_exo1 | 4.44e-04 | 4 | 162 | 2 | PF03104 | |
| Domain | G2_nidogen/fibulin_G2F | 4.44e-04 | 4 | 162 | 2 | IPR006605 | |
| Domain | POLBc | 4.44e-04 | 4 | 162 | 2 | SM00486 | |
| Domain | fn3 | 5.37e-04 | 162 | 162 | 7 | PF00041 | |
| Domain | YD | 7.35e-04 | 5 | 162 | 2 | IPR006530 | |
| Domain | GPCR_Rhodpsn_7TM | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B HCRTR1 | 7.47e-04 | 670 | 162 | 15 | IPR017452 |
| Domain | GPCR_3 | 7.60e-04 | 21 | 162 | 3 | IPR000337 | |
| Domain | 7tm_1 | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B HCRTR1 | 8.30e-04 | 677 | 162 | 15 | PF00001 |
| Domain | 7tm_3 | 8.74e-04 | 22 | 162 | 3 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 8.74e-04 | 22 | 162 | 3 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 8.74e-04 | 22 | 162 | 3 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 8.74e-04 | 22 | 162 | 3 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 8.74e-04 | 22 | 162 | 3 | PS50259 | |
| Domain | GPCR_3_C | 8.74e-04 | 22 | 162 | 3 | IPR017978 | |
| Domain | G_PROTEIN_RECEP_F1_1 | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B HCRTR1 | 9.34e-04 | 685 | 162 | 15 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B HCRTR1 | 1.02e-03 | 691 | 162 | 15 | PS50262 |
| Domain | GPCR_Rhodpsn | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 MRGPRE NTSR1 NMUR2 OR10R2 ADORA2B OR5J2 ADRA2A ADRA2B HCRTR1 | 1.03e-03 | 692 | 162 | 15 | IPR000276 |
| Domain | FN3 | 1.17e-03 | 185 | 162 | 7 | SM00060 | |
| Domain | Ig_I-set | 1.37e-03 | 190 | 162 | 7 | IPR013098 | |
| Domain | I-set | 1.37e-03 | 190 | 162 | 7 | PF07679 | |
| Domain | TLV_coat | 1.53e-03 | 7 | 162 | 2 | PF00429 | |
| Domain | Cullin_CS | 1.53e-03 | 7 | 162 | 2 | IPR016157 | |
| Domain | CULLIN | 1.53e-03 | 7 | 162 | 2 | SM00182 | |
| Domain | FN3 | 1.78e-03 | 199 | 162 | 7 | PS50853 | |
| Domain | Aden_trnslctor | 1.79e-03 | 28 | 162 | 3 | IPR002113 | |
| Domain | - | COL12A1 NRCAM NFASC CMYA5 JAM2 LRIG3 HHLA2 SEMA3D PTPRB HMCN1 NFATC1 PTPRM ROBO1 IL1R1 | 1.94e-03 | 663 | 162 | 14 | 2.60.40.10 |
| Domain | Cullin_neddylation_domain | 2.02e-03 | 8 | 162 | 2 | IPR019559 | |
| Domain | GPCR_3_mtglu_rcpt | 2.02e-03 | 8 | 162 | 2 | IPR000162 | |
| Domain | Cullin_Nedd8 | 2.02e-03 | 8 | 162 | 2 | PF10557 | |
| Domain | Cullin_Nedd8 | 2.02e-03 | 8 | 162 | 2 | SM00884 | |
| Domain | TLV/ENV_coat_polyprotein | 2.02e-03 | 8 | 162 | 2 | IPR018154 | |
| Domain | FN3_dom | 2.35e-03 | 209 | 162 | 7 | IPR003961 | |
| Domain | Cullin_homology | 2.59e-03 | 9 | 162 | 2 | IPR016158 | |
| Domain | 5HT_rcpt | 2.59e-03 | 9 | 162 | 2 | IPR002231 | |
| Domain | Plexin_repeat | 2.64e-03 | 32 | 162 | 3 | IPR002165 | |
| Domain | PSI | 2.64e-03 | 32 | 162 | 3 | PF01437 | |
| Domain | Mit_carrier | 2.64e-03 | 32 | 162 | 3 | IPR002067 | |
| Domain | A2M | 3.21e-03 | 10 | 162 | 2 | PF00207 | |
| Domain | A2M_N_2 | 3.21e-03 | 10 | 162 | 2 | IPR011625 | |
| Domain | A2M_comp | 3.21e-03 | 10 | 162 | 2 | IPR011626 | |
| Domain | Cullin | 3.21e-03 | 10 | 162 | 2 | PF00888 | |
| Domain | A2M_recep | 3.21e-03 | 10 | 162 | 2 | PF07677 | |
| Domain | A2M_comp | 3.21e-03 | 10 | 162 | 2 | PF07678 | |
| Domain | Hud_Sxl_RNA | 3.21e-03 | 10 | 162 | 2 | IPR002343 | |
| Domain | A2M_N | 3.21e-03 | 10 | 162 | 2 | PF01835 | |
| Domain | A2M_N | 3.21e-03 | 10 | 162 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 3.21e-03 | 10 | 162 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 3.21e-03 | 10 | 162 | 2 | PS00477 | |
| Domain | CULLIN_2 | 3.21e-03 | 10 | 162 | 2 | PS50069 | |
| Domain | A2M_N_2 | 3.21e-03 | 10 | 162 | 2 | PF07703 | |
| Domain | Cullin_N | 3.21e-03 | 10 | 162 | 2 | IPR001373 | |
| Domain | ADR_fam | 3.21e-03 | 10 | 162 | 2 | IPR002233 | |
| Domain | Macroglobln_a2 | 3.21e-03 | 10 | 162 | 2 | IPR001599 | |
| Domain | CULLIN_1 | 3.21e-03 | 10 | 162 | 2 | PS01256 | |
| Domain | Ig-like_fold | COL12A1 NRCAM NFASC CMYA5 JAM2 LRIG3 HHLA2 SEMA3D PTPRB HMCN1 NFATC1 PTPRM ROBO1 IL1R1 | 3.42e-03 | 706 | 162 | 14 | IPR013783 |
| Domain | PTPc | 3.71e-03 | 36 | 162 | 3 | SM00194 | |
| Domain | IG | 3.78e-03 | 421 | 162 | 10 | SM00409 | |
| Domain | Ig_sub | 3.78e-03 | 421 | 162 | 10 | IPR003599 | |
| Domain | GFP-like | 3.91e-03 | 11 | 162 | 2 | IPR023413 | |
| Domain | - | 3.91e-03 | 11 | 162 | 2 | 2.40.155.10 | |
| Domain | NA_SOLUT_SYMP_1 | 3.91e-03 | 11 | 162 | 2 | PS00456 | |
| Domain | Cadherin_tail | 4.01e-03 | 37 | 162 | 3 | PF15974 | |
| Domain | ANF_lig-bd_rcpt | 4.01e-03 | 37 | 162 | 3 | IPR001828 | |
| Domain | Cadherin_CBD | 4.01e-03 | 37 | 162 | 3 | IPR031904 | |
| Domain | ANF_receptor | 4.01e-03 | 37 | 162 | 3 | PF01094 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 GRM3 GRM7 ADORA2B ADRA2A ADRA2B TAS1R2 CCL3 C3 TAS2R40 HCRTR1 | 1.01e-06 | 430 | 123 | 16 | MM15160 |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 GRM3 GRM7 ADORA2B ADRA2A ADRA2B TAS1R2 CCL3 C3 TAS2R40 HCRTR1 | 2.65e-06 | 463 | 123 | 16 | M507 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | GPR12 DRD2 HTR1D GALR1 HTR2A GPR34 NTSR1 NMUR2 ADORA2B ADRA2A ADRA2B HCRTR1 | 2.82e-06 | 260 | 123 | 12 | M39397 |
| Pathway | WP_GPCRS_NONODORANT | DRD2 HTR1D GALR1 NTSR1 NMUR2 GRM3 GRM7 ADORA2B ADRA2A ADRA2B TAS2R40 HCRTR1 | 3.57e-06 | 266 | 123 | 12 | MM15843 |
| Pathway | KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 GRM3 GRM7 ADORA2B ADRA2A ADRA2B HCRTR1 | 4.49e-06 | 272 | 123 | 12 | M13380 |
| Pathway | WP_MONOAMINE_GPCRS | 9.10e-06 | 33 | 123 | 5 | M39585 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.62e-05 | 37 | 123 | 5 | M1029 | |
| Pathway | REACTOME_NEUROFASCIN_INTERACTIONS | 2.21e-05 | 7 | 123 | 3 | M27380 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.06e-05 | 42 | 123 | 5 | M5868 | |
| Pathway | REACTOME_AMINE_LIGAND_BINDING_RECEPTORS | 3.06e-05 | 42 | 123 | 5 | MM14971 | |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 ADORA2B ADRA2A ADRA2B CCL3 C3 HCRTR1 | 3.12e-05 | 330 | 123 | 12 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 ADORA2B ADRA2A ADRA2B CCL3 C3 HCRTR1 | 3.40e-05 | 333 | 123 | 12 | MM14963 |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 4.30e-05 | 23 | 123 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 7.44e-05 | 10 | 123 | 3 | M47694 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | HTR1D GALR1 NMUR2 GRM3 GRM7 ADRA2A ADRA2B PPP3CB TAS1R2 C3 TAS2R40 | 9.43e-05 | 314 | 123 | 11 | M600 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 GRM3 GRM7 ADORA2B ADRA2A ADRA2B PPP3CB TAS1R2 CCL3 C3 TAS2R40 HCRTR1 | 1.24e-04 | 702 | 123 | 17 | M746 |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 1.35e-04 | 12 | 123 | 3 | M27728 | |
| Pathway | WP_MONOAMINE_GPCRS | 1.45e-04 | 31 | 123 | 4 | MM15871 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | DRD2 HTR1D GALR1 HTR2A NTSR1 NMUR2 GRM3 GRM7 ADORA2B ADRA2A ADRA2B TAS1R2 CCL3 C3 TAS2R40 HCRTR1 | 1.54e-04 | 646 | 123 | 16 | MM14962 |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.65e-04 | 178 | 123 | 8 | M2890 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.74e-04 | 13 | 123 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 1.74e-04 | 13 | 123 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.74e-04 | 13 | 123 | 3 | M47703 | |
| Pathway | REACTOME_G_ALPHA_I_SIGNALLING_EVENTS | 2.19e-04 | 289 | 123 | 10 | MM15057 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 2.20e-04 | 14 | 123 | 3 | M47692 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 2.24e-04 | 186 | 123 | 8 | MM15994 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 2.73e-04 | 15 | 123 | 3 | M47691 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 2.92e-04 | 37 | 123 | 4 | MM15067 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 3.34e-04 | 16 | 123 | 3 | M47695 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 3.58e-04 | 39 | 123 | 4 | M793 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.81e-04 | 18 | 123 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 4.81e-04 | 18 | 123 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 5.67e-04 | 19 | 123 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 5.67e-04 | 19 | 123 | 3 | M47760 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 6.12e-04 | 271 | 123 | 9 | MM15406 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 6.63e-04 | 20 | 123 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 7.69e-04 | 21 | 123 | 3 | M47689 | |
| Pathway | WP_PROGERIAASSOCIATED_LIPODYSTROPHY | 8.84e-04 | 22 | 123 | 3 | M42534 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.84e-04 | 22 | 123 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.84e-04 | 22 | 123 | 3 | M47675 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 9.43e-04 | 288 | 123 | 9 | M16864 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 1.00e-03 | 131 | 123 | 6 | M5283 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.01e-03 | 23 | 123 | 3 | M47676 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.15e-03 | 24 | 123 | 3 | MM15658 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.52e-03 | 249 | 123 | 8 | M5988 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.63e-03 | 27 | 123 | 3 | M29807 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.63e-03 | 27 | 123 | 3 | M47755 | |
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 6.48e-10 | 4 | 177 | 4 | 10469592 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | ERVK-6 ERVV-2 ERVK-7 ERVK-10 ERVK-8 ERVK-19 ERVV-1 ERVK-25 ERVK-24 | 1.37e-09 | 94 | 177 | 9 | 21542922 |
| Pubmed | DRD2 HTR1D GALR1 HTR2A NRCAM CNTNAP1 NTSR1 GRM3 GRM7 SLC1A6 ADORA2B ADRA2A HCRTR1 | 5.47e-09 | 300 | 177 | 13 | 19086053 | |
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 12450408 | ||
| Pubmed | 1.30e-07 | 3 | 177 | 3 | 31704949 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 1.30e-07 | 3 | 177 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 1.30e-07 | 3 | 177 | 3 | 2829183 | |
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 21949117 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 33396658 | ||
| Pubmed | 5.16e-07 | 4 | 177 | 3 | 7983737 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.29e-06 | 5 | 177 | 3 | 12629516 | |
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 10620603 | ||
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 23085571 | ||
| Pubmed | 2.56e-06 | 6 | 177 | 3 | 20188654 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXA COL12A1 MAN2B2 ATR GPS1 CNTNAP1 SLC35E1 RECQL C1RL ABCA7 NUP35 DMXL1 XYLT2 CSGALNACT2 LOXL1 LPCAT3 JMJD8 SLITRK5 ROBO1 DNASE2 | 3.59e-06 | 1201 | 177 | 20 | 35696571 |
| Pubmed | 4.47e-06 | 7 | 177 | 3 | 21370995 | ||
| Pubmed | Association study of 182 candidate genes in anorexia nervosa. | 4.62e-06 | 182 | 177 | 8 | 20468064 | |
| Pubmed | Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. | 6.36e-06 | 24 | 177 | 4 | 24725412 | |
| Pubmed | 7.12e-06 | 8 | 177 | 3 | 27641616 | ||
| Pubmed | The human RNA surveillance factor UPF1 is required for S phase progression and genome stability. | 1.06e-05 | 9 | 177 | 3 | 16488880 | |
| Pubmed | Clustered gamma-protocadherins regulate cortical interneuron programmed cell death. | 1.09e-05 | 57 | 177 | 5 | 32633719 | |
| Pubmed | 1.19e-05 | 58 | 177 | 5 | 11140838 | ||
| Pubmed | Age-dependent effects of Armc5 haploinsufficiency on adrenocortical function. | 1.21e-05 | 28 | 177 | 4 | 28911199 | |
| Pubmed | 1.21e-05 | 28 | 177 | 4 | 19352218 | ||
| Pubmed | 1.51e-05 | 10 | 177 | 3 | 17156446 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24872568 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23808549 | ||
| Pubmed | Type XII collagen contributes to diversities in human corneal and limbal extracellular matrices. | 2.58e-05 | 2 | 177 | 2 | 9344363 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 6203109 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 18511303 | ||
| Pubmed | The calcineurin-NFAT axis contributes to host defense during Pseudomonas aeruginosa lung infection. | 2.58e-05 | 2 | 177 | 2 | 29018150 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 8922386 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 20888323 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 2824652 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26842067 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 18826608 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 2.58e-05 | 2 | 177 | 2 | 14749836 | |
| Pubmed | ATR-dependent phosphorylation of FANCM at serine 1045 is essential for FANCM functions. | 2.58e-05 | 2 | 177 | 2 | 23698467 | |
| Pubmed | Isolation and expression of Napor/CUG-BP2 in embryo development. | 2.58e-05 | 2 | 177 | 2 | 12763013 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28075014 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21541285 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26206285 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 15140279 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 28692863 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 31571100 | ||
| Pubmed | The receptor protein-tyrosine phosphatase PTPmu interacts with IQGAP1. | 2.58e-05 | 2 | 177 | 2 | 16380380 | |
| Pubmed | Protein phosphatase 5 is required for ATR-mediated checkpoint activation. | 2.58e-05 | 2 | 177 | 2 | 16260606 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 21384582 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23555306 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 12112115 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 10737629 | ||
| Pubmed | Protein phosphatase 5 is necessary for ATR-mediated DNA repair. | 2.58e-05 | 2 | 177 | 2 | 21144835 | |
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 2.58e-05 | 2 | 177 | 2 | 10926541 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 31761670 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 23468433 | ||
| Pubmed | Activation of alpha 2B-adrenoceptors mediates the cardiovascular effects of etomidate. | 2.58e-05 | 2 | 177 | 2 | 14508322 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 37524709 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 29351780 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 9060628 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 25175457 | ||
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 2.58e-05 | 2 | 177 | 2 | 9460924 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 24682224 | ||
| Pubmed | Dopamine D2 receptor signaling dynamics of dopamine D2-neurotensin 1 receptor heteromers. | 2.58e-05 | 2 | 177 | 2 | 23624386 | |
| Pubmed | Accumulation of Neurofascin at Nodes of Ranvier Is Regulated by a Paranodal Switch. | 2.58e-05 | 2 | 177 | 2 | 32554548 | |
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 27048932 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 16556444 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 2823266 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 26755646 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 18691636 | ||
| Pubmed | 2.58e-05 | 2 | 177 | 2 | 25563748 | ||
| Pubmed | Expression and sequence analysis of the mouse adenine nucleotide translocase 1 and 2 genes. | 2.58e-05 | 2 | 177 | 2 | 10974536 | |
| Pubmed | Cigarette smoke induces PTX3 expression in pulmonary veins of mice in an IL-1 dependent manner. | 2.58e-05 | 2 | 177 | 2 | 20920344 | |
| Pubmed | A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. | 2.58e-05 | 2 | 177 | 2 | 11756613 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 2.59e-05 | 68 | 177 | 5 | 11230163 | |
| Pubmed | 2.76e-05 | 12 | 177 | 3 | 16120388 | ||
| Pubmed | 2.76e-05 | 12 | 177 | 3 | 14557543 | ||
| Pubmed | Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program. | 2.92e-05 | 171 | 177 | 7 | 28700664 | |
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 3.28e-05 | 118 | 177 | 6 | 19156168 | |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 3.43e-05 | 72 | 177 | 5 | 10380929 | |
| Pubmed | 3.57e-05 | 13 | 177 | 3 | 17655760 | ||
| Pubmed | 3.91e-05 | 179 | 177 | 7 | 18577758 | ||
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.91e-05 | 74 | 177 | 5 | 10817752 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.31e-05 | 248 | 177 | 8 | 24006456 | |
| Pubmed | 4.53e-05 | 14 | 177 | 3 | 28826478 | ||
| Pubmed | 4.74e-05 | 77 | 177 | 5 | 10835267 | ||
| Pubmed | 5.64e-05 | 15 | 177 | 3 | 23515096 | ||
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 5.70e-05 | 80 | 177 | 5 | 10716726 | |
| Pubmed | 6.91e-05 | 16 | 177 | 3 | 8649810 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 25637489 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 32124190 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 9415717 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 17261653 | ||
| Pubmed | PPP3CB Inhibits Cell Proliferation and the Warburg Effect in Bladder Cancer by Blocking PDHK1. | 7.70e-05 | 3 | 177 | 2 | 38420800 | |
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 21441447 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 1655529 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 21427212 | ||
| Pubmed | Effect of DRD2, 5-HT2A, and COMT genes on antipsychotic response to risperidone. | 7.70e-05 | 3 | 177 | 2 | 14610521 | |
| Pubmed | Regulation of alpha(2)-adrenoceptors in human vascular smooth muscle cells. | 7.70e-05 | 3 | 177 | 2 | 12946937 | |
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 20613626 | ||
| Pubmed | 7.70e-05 | 3 | 177 | 2 | 18480698 | ||
| Cytoband | 5q31 | 8.77e-05 | 115 | 177 | 5 | 5q31 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.71e-05 | 161 | 126 | 8 | 593 | |
| GeneFamily | Clustered protocadherins | 8.33e-05 | 64 | 126 | 5 | 20 | |
| GeneFamily | Fibronectin type III domain containing | 1.30e-04 | 160 | 126 | 7 | 555 | |
| GeneFamily | Dyneins, axonemal | 2.09e-04 | 17 | 126 | 3 | 536 | |
| GeneFamily | Neuroblastoma breakpoint family | 5.29e-04 | 23 | 126 | 3 | 662 | |
| GeneFamily | Cullins | 1.31e-03 | 8 | 126 | 2 | 1032 | |
| GeneFamily | Glutamate metabotropic receptors|Protein phosphatase 1 regulatory subunits | 1.31e-03 | 8 | 126 | 2 | 281 | |
| GeneFamily | Nucleoporins | 1.41e-03 | 32 | 126 | 3 | 1051 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 1.68e-03 | 9 | 126 | 2 | 1234 | |
| GeneFamily | Adrenoceptors | 1.68e-03 | 9 | 126 | 2 | 169 | |
| GeneFamily | Solute carriers | SLC25A4 SLC25A5 SLC25A6 SLC35E1 SLC1A6 SLC5A2 SLC5A11 SLC7A8 SLC8B1 | 1.80e-03 | 395 | 126 | 9 | 752 |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 3.57e-03 | 13 | 126 | 2 | 693 | |
| GeneFamily | 5-hydroxytryptamine receptors, G protein-coupled | 3.57e-03 | 13 | 126 | 2 | 170 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | CUL3 GPR12 NAALAD2 COL12A1 NTSR1 PCDHB13 OLFM4 UBA3 G2E3 GRM3 CUL5 INTS10 SEMA3D ADRA2A DMRT3 HMCN1 NFATC1 PTX3 PAPPA | 1.25e-05 | 819 | 159 | 19 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | COL12A1 NRCAM REV3L LXN STC1 TENM4 NFATC1 ATRNL1 ROBO1 PAPPA IL1R1 | 1.16e-10 | 182 | 169 | 11 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|metastatic_Lymph_Node / Location, Cell class and cell subclass | 2.09e-08 | 172 | 169 | 9 | f673a2e697b46e7cfa4186cb3fb2b98e3c83703e | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.95e-08 | 179 | 169 | 9 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-08 | 184 | 169 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-08 | 184 | 169 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-08 | 184 | 169 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.30e-08 | 187 | 169 | 9 | c104fbfef2d0bef64077ac721edf2379fd59d547 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 4.71e-08 | 189 | 169 | 9 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.35e-07 | 173 | 169 | 8 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-07 | 174 | 169 | 8 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | (05)_Ciliated-(2)_48hpi|(05)_Ciliated / shred by cell type and Timepoint | 4.85e-07 | 124 | 169 | 7 | fc8cce8c1809edafbc4e69e501dd4f016f5dfc0b | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.67e-07 | 193 | 169 | 8 | cf2461af78f65616ce40d552ee9452295e3895ed | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.67e-07 | 193 | 169 | 8 | 6ef9007c9d18fb775d08fb20cdf954a28d54d7eb | |
| ToppCell | 10x5'v1-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 7.67e-07 | 193 | 169 | 8 | e4ea7ce011a80b81b841c907719aa532bed39d2e | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.29e-07 | 195 | 169 | 8 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 8.95e-07 | 197 | 169 | 8 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.00e-06 | 200 | 169 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 1.05e-06 | 139 | 169 | 7 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-Microglia/Mac|Myeloid_cells / Location, Cell class and cell subclass | 3.85e-06 | 169 | 169 | 7 | dba8f5599aa21feef5b7fdfed2e3ab54748d80f7 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.00e-06 | 170 | 169 | 7 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Myofibro_3|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 6.50e-06 | 183 | 169 | 7 | f4ea7113ce9099222743d9ff02388d3d8a9e987b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.73e-06 | 184 | 169 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.97e-06 | 185 | 169 | 7 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.97e-06 | 185 | 169 | 7 | 10da5c2a92bfb3248d3f6f94a0933996326cf590 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.22e-06 | 186 | 169 | 7 | a906020a8df6fcca474b278f746c553b177a56b4 | |
| ToppCell | metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 7.48e-06 | 187 | 169 | 7 | e04fb35f2f5b120659d06b5ae427ab1ec56d5c36 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.75e-06 | 188 | 169 | 7 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.30e-06 | 190 | 169 | 7 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.89e-06 | 192 | 169 | 7 | 5b7093d5af5ae7b0e6d3a464cc56272440ecedad | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-06 | 192 | 169 | 7 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts-Subpleural_fibroblasts_L.2.1.5.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.83e-06 | 195 | 169 | 7 | 0866aaf053762d1a021fcbccff058526078a99da | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.83e-06 | 195 | 169 | 7 | 51db90e7611f7d69980878c046505ff34212079b | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 197 | 169 | 7 | 26475b9e4d6bfc0ae818dea13d139888ed7e92f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-05 | 197 | 169 | 7 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 197 | 169 | 7 | 155e63b33302a87393ace699b2f6d73abe9c5763 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 198 | 169 | 7 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-05 | 198 | 169 | 7 | a4005a49cf6709b543994ceb51ecd5dc46197fa9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.09e-05 | 198 | 169 | 7 | 229588189825b1080181db9515185677b742c668 | |
| ToppCell | distal-1-mesenchymal-Mesothelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.12e-05 | 199 | 169 | 7 | 8dd5b411d2f1626830b77a1616cc3fb67dc59338 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | ba586690f88fd051f449753bfe7603a2cb431782 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-05 | 199 | 169 | 7 | 9c40b3ee39860e9d8edafd007daec11abdd95435 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | 06a7d874ff7c4616577f6e59d3118717a8c47c00 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | 211c3a08f2d484ab7a3368006767289088f0d957 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.12e-05 | 199 | 169 | 7 | 72b34bce8157abe389e95cd3ed8ba578dce0cbf6 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts|LPS_only / Treatment groups by lineage, cell group, cell type | 1.12e-05 | 199 | 169 | 7 | 1a0add79f4e34078b3475eb11c85a4234bda197c | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | 64ae5cf6cb4fc94cf1052abd82648f6b8e6445fe | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-05 | 200 | 169 | 7 | 93c1db92e0e456101f7895867fc8a1fe45298347 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Mesothelial-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.16e-05 | 200 | 169 | 7 | 3be373e9a30e19334e4709e2819fb83cc777d104 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | a1fc74c1b27e104895910bc7cdce7ba33d30df7e | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Mesothelial-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-05 | 200 | 169 | 7 | 46d0ae385e67030bfaf7062bb6b43da5db05b33a | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 1.16e-05 | 200 | 169 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Subpleural_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 200 | 169 | 7 | d64895354218ebd0217011bae0967a6883bbd1cd | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)-Drd1|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.02e-05 | 146 | 169 | 6 | 7b863f9bc63dc1afe015a18a70cd6ed0b71d1f09 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.75e-05 | 163 | 169 | 6 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-05 | 169 | 169 | 6 | f2e20049a17eee533d49bd5f24a51962d123d132 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-basophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.59e-05 | 169 | 169 | 6 | 4c6892551e9dec94fc62b3beab1e6d424639a1e9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.74e-05 | 170 | 169 | 6 | 3174ea9cf93892a8b41de10fd4ff6f06bb41502d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.74e-05 | 170 | 169 | 6 | 5de2f7d16a05af74ebfb1ca42d0f9c3c3524692d | |
| ToppCell | Ionocyte-iono-2|World / Class top | 5.22e-05 | 173 | 169 | 6 | e5ec28ccc5e048fd98de4c876e5c53b866b66228 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.22e-05 | 173 | 169 | 6 | 9a2d42f8d9cb834856522661d524abb91c4637c5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Myeloid_Dendritic_Type_1|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 174 | 169 | 6 | ff13a5c55d18b951315908f33cb47c7f9cb901bf | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.39e-05 | 174 | 169 | 6 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 5.57e-05 | 175 | 169 | 6 | 2eca4c168dea2017ea0e383006e28abed22f32ec | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.57e-05 | 175 | 169 | 6 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 176 | 169 | 6 | 8e4600efeea095a92178cfd26d7c58db7dfc0c80 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.75e-05 | 176 | 169 | 6 | 40993c41c1017b53039a337174fc56632b278609 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 176 | 169 | 6 | c4d9166e5bbb7ca544107db14e4374289f5de6bd | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-05 | 176 | 169 | 6 | d58ef51002ea50b3037636038214bbb7454cb503 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.93e-05 | 177 | 169 | 6 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 177 | 169 | 6 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | Endothelial-Endothelial-C|Endothelial / shred on cell class and cell subclass (v4) | 5.93e-05 | 177 | 169 | 6 | b5b9278dfd76b1aacd88e5fe86e91a2c9b565f87 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.93e-05 | 177 | 169 | 6 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 178 | 169 | 6 | fcbbcc44271515de1969b4732b6441c012693d5f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.12e-05 | 178 | 169 | 6 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.12e-05 | 178 | 169 | 6 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | c7f5aedcb74c21fb587a95a16d700e2a38a380ee | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal-kidney_interstitial_fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | 0ec9621a078d004bbd25a587757d24b5cf162959 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | 7286700396676fdc41d9723979b8b408177aceb9 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.71e-05 | 181 | 169 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | PCW_05-06-Neuronal-Neuronal_SCP|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.92e-05 | 182 | 169 | 6 | b4fc5e4f5d8440a3c9ee0a6fd0da87b43cabc8c6 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 7.13e-05 | 183 | 169 | 6 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.13e-05 | 183 | 169 | 6 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CACNG5|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.35e-05 | 184 | 169 | 6 | 658f2e522055e88c92bc482a845c40f8f5f1a8e3 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.35e-05 | 184 | 169 | 6 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.57e-05 | 185 | 169 | 6 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 185 | 169 | 6 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.57e-05 | 185 | 169 | 6 | 5527fa9d2e0b2f3607602e18ba94de4e9bbc6824 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 7.57e-05 | 185 | 169 | 6 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.57e-05 | 185 | 169 | 6 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.57e-05 | 185 | 169 | 6 | d42dcc92a34fcdabf112565fbd5fd26cbd4de58a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.80e-05 | 186 | 169 | 6 | 94d577dbb6bfacf50632e1fe8af041b35a1e6b23 | |
| ToppCell | Control-Myeloid-cDC1|Control / Disease state, Lineage and Cell class | 7.80e-05 | 186 | 169 | 6 | b05c394aa3573ba855abc3066739ca193883b0c3 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.80e-05 | 186 | 169 | 6 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_adipo|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.03e-05 | 187 | 169 | 6 | f1d0fc625e0e7881b3f290742fd7148d995eb71e | |
| Computational | Vesicular transport / synapse genes. | 1.37e-04 | 82 | 104 | 6 | MODULE_274 | |
| Computational | Genes in the cancer module 289. | 1.93e-04 | 124 | 104 | 7 | MODULE_289 | |
| Computational | GPCR signaling pathways (immune and neuro). | 2.29e-04 | 90 | 104 | 6 | MODULE_375 | |
| Drug | clorgyline | 3.89e-09 | 75 | 166 | 9 | CID000004380 | |
| Drug | Yohimbine | 4.75e-09 | 10 | 166 | 5 | DB01392 | |
| Drug | Ergotamine | 4.75e-09 | 10 | 166 | 5 | DB00696 | |
| Drug | Lisuride | 3.68e-08 | 14 | 166 | 5 | DB00589 | |
| Drug | Pramipexole | 3.68e-08 | 14 | 166 | 5 | DB00413 | |
| Drug | Ropinirole | 3.68e-08 | 14 | 166 | 5 | DB00268 | |
| Drug | Risperidone | 3.68e-08 | 14 | 166 | 5 | DB00734 | |
| Drug | Cabergoline | 5.49e-08 | 15 | 166 | 5 | DB00248 | |
| Drug | Apomorphine | 5.49e-08 | 15 | 166 | 5 | DB00714 | |
| Drug | KW-6002 | 1.06e-07 | 32 | 166 | 6 | CID005311037 | |
| Drug | Paliperidone | 1.12e-07 | 17 | 166 | 5 | DB01267 | |
| Drug | Pergolide | 1.12e-07 | 17 | 166 | 5 | DB01186 | |
| Drug | S 15535 | 1.12e-07 | 17 | 166 | 5 | CID000132787 | |
| Drug | Bromocriptine | 1.54e-07 | 18 | 166 | 5 | DB01200 | |
| Drug | S 14489 | 1.86e-07 | 8 | 166 | 4 | CID000182595 | |
| Drug | molindone | 2.23e-07 | 36 | 166 | 6 | CID000023897 | |
| Drug | phenylethylamine | 2.88e-07 | 89 | 166 | 8 | CID000001001 | |
| Drug | pipamperone | 3.12e-07 | 38 | 166 | 6 | CID000004830 | |
| Drug | S 15931 | 3.34e-07 | 9 | 166 | 4 | CID000182596 | |
| Drug | CAS 66104-23-2 | 3.79e-07 | 63 | 166 | 7 | CID000004745 | |
| Drug | Clodronate | 3.81e-07 | 3 | 166 | 3 | DB00720 | |
| Drug | S 14671 | 5.53e-07 | 10 | 166 | 4 | CID000131907 | |
| Drug | Olanzapine | 9.16e-07 | 25 | 166 | 5 | DB00334 | |
| Drug | Ziprasidone | 9.16e-07 | 25 | 166 | 5 | DB00246 | |
| Drug | Aripiprazole | 9.16e-07 | 25 | 166 | 5 | DB01238 | |
| Drug | Clozapine | 1.13e-06 | 26 | 166 | 5 | DB00363 | |
| Drug | Quetiapine | 1.13e-06 | 26 | 166 | 5 | DB01224 | |
| Drug | T15550 | 1.13e-06 | 26 | 166 | 5 | CID000005454 | |
| Drug | NSC169490 | 1.38e-06 | 27 | 166 | 5 | CID004210613 | |
| Drug | dehydroabietylamine | 1.51e-06 | 4 | 166 | 3 | ctd:C000600819 | |
| Drug | 2-methoxyidazoxan | 1.51e-06 | 4 | 166 | 3 | ctd:C058525 | |
| Drug | roxindole | 1.66e-06 | 28 | 166 | 5 | CID000219050 | |
| Drug | L-741,626 | 1.66e-06 | 28 | 166 | 5 | CID000133633 | |
| Drug | sertindole | 1.67e-06 | 50 | 166 | 6 | CID000060149 | |
| Drug | trazodone | 1.88e-06 | 51 | 166 | 6 | CID000005533 | |
| Drug | AC1L1G8Z | 2.38e-06 | 30 | 166 | 5 | CID000003581 | |
| Drug | mirtazapine | 2.65e-06 | 54 | 166 | 6 | CID000004205 | |
| Drug | MHPG | 3.66e-06 | 57 | 166 | 6 | CID000010805 | |
| Drug | idazoxan | 4.02e-06 | 89 | 166 | 7 | CID000054459 | |
| Drug | transdihydrolisuride | 4.55e-06 | 34 | 166 | 5 | CID000005406 | |
| Drug | L-DOPA methyl ester | 4.63e-06 | 16 | 166 | 4 | CID000023497 | |
| Drug | N-ethylmaleimide | HEXA ERVK-6 MYH7 DRD2 HTR2A SLC25A4 SLC25A5 SLC25A6 POLD1 REV3L SLC7A8 ADORA2B MYO3B SYNGR2 KIF5A | 5.39e-06 | 511 | 166 | 15 | CID000004362 |
| Drug | AC-680 | 5.40e-06 | 93 | 166 | 7 | CID000004691 | |
| Drug | AC1MHW5N | 6.09e-06 | 36 | 166 | 5 | CID003058747 | |
| Drug | iloperidone | 6.09e-06 | 36 | 166 | 5 | CID000071360 | |
| Drug | Zuclopenthixol | 7.49e-06 | 6 | 166 | 3 | DB01624 | |
| Drug | S-(-)-Lisuride | 7.94e-06 | 65 | 166 | 6 | CID000003938 | |
| Drug | reboxetine | 9.48e-06 | 67 | 166 | 6 | CID000065856 | |
| Drug | Ro 41-9067 | 9.70e-06 | 19 | 166 | 4 | CID000125800 | |
| Drug | Methotrimeprazine | 9.70e-06 | 19 | 166 | 4 | DB01403 | |
| Drug | NSC95090 | 1.04e-05 | 40 | 166 | 5 | CID000003251 | |
| Drug | Saphris | 1.18e-05 | 41 | 166 | 5 | CID000163091 | |
| Drug | ICI 169,369 | 1.21e-05 | 20 | 166 | 4 | CID000122265 | |
| Drug | GBR 12935 | 1.21e-05 | 20 | 166 | 4 | CID000003456 | |
| Drug | Doxepin | 1.21e-05 | 20 | 166 | 4 | DB01142 | |
| Drug | Lurasidone Hydrochloride | 1.30e-05 | 7 | 166 | 3 | ctd:D000069056 | |
| Drug | closantel | 1.30e-05 | 7 | 166 | 3 | ctd:C023342 | |
| Drug | spiroxatrine | 1.33e-05 | 42 | 166 | 5 | CID000005268 | |
| Drug | EEDQ | 1.44e-05 | 72 | 166 | 6 | CID000027833 | |
| Drug | LY341495 | 1.49e-05 | 43 | 166 | 5 | CID006324636 | |
| Drug | Etanidazole [22668-01-5]; Up 200; 18.6uM; PC3; HT_HG-U133A | 1.68e-05 | 200 | 166 | 9 | 5730_UP | |
| Drug | AC1L5AAF | 2.08e-05 | 8 | 166 | 3 | CID000173615 | |
| Drug | NRA 0045 | 2.08e-05 | 8 | 166 | 3 | ctd:C106996 | |
| Drug | loxapine | 2.09e-05 | 46 | 166 | 5 | CID000003964 | |
| Drug | methiothepin | 2.12e-05 | 77 | 166 | 6 | CID000004106 | |
| Drug | droperidol | 2.17e-05 | 23 | 166 | 4 | CID000003168 | |
| Drug | B-HT 920 | 2.32e-05 | 47 | 166 | 5 | CID000005374 | |
| Drug | NAN-190 | 2.32e-05 | 47 | 166 | 5 | CID000004431 | |
| Drug | 8-OH-DPAT | 2.44e-05 | 117 | 166 | 7 | CID000001220 | |
| Drug | Ergot | 2.58e-05 | 48 | 166 | 5 | CID000003250 | |
| Drug | buspirone | 2.64e-05 | 80 | 166 | 6 | CID000002477 | |
| Drug | clomipramine | 2.64e-05 | 80 | 166 | 6 | CID000002801 | |
| Drug | WAY-100635 | 2.85e-05 | 49 | 166 | 5 | CID000005684 | |
| Drug | zotepine | 2.85e-05 | 49 | 166 | 5 | CID000005736 | |
| Drug | Phenyl-P | 3.10e-05 | 9 | 166 | 3 | CID006454947 | |
| Drug | etilevodopa | 3.10e-05 | 9 | 166 | 3 | CID000170345 | |
| Drug | AC1Q7BEJ | 3.15e-05 | 50 | 166 | 5 | CID000001224 | |
| Drug | FLA-63 | 3.59e-05 | 26 | 166 | 4 | CID000033295 | |
| Drug | piperoxan | 3.59e-05 | 26 | 166 | 4 | CID000006040 | |
| Drug | p-chlorophenylalanine | 3.98e-05 | 86 | 166 | 6 | CID000004652 | |
| Drug | mianserin | 4.25e-05 | 87 | 166 | 6 | CID000004184 | |
| Drug | ziprasidone | 4.40e-05 | 10 | 166 | 3 | ctd:C092292 | |
| Drug | S 14297 | 4.40e-05 | 10 | 166 | 3 | CID000115007 | |
| Drug | AC1L4X2K | 4.40e-05 | 10 | 166 | 3 | CID000193824 | |
| Drug | olanzapine | 4.57e-05 | 129 | 166 | 7 | CID000004585 | |
| Drug | Napamezol | 5.28e-05 | 2 | 166 | 2 | CID000124655 | |
| Drug | irindalone | 5.28e-05 | 2 | 166 | 2 | CID000065845 | |
| Drug | Mesoridazine | 5.28e-05 | 2 | 166 | 2 | DB00933 | |
| Drug | Wy 27127 | 5.28e-05 | 2 | 166 | 2 | CID000125697 | |
| Drug | 4-chlorophenylacetic acid | 5.49e-05 | 56 | 166 | 5 | CID000015880 | |
| Drug | norclozapine | 5.98e-05 | 57 | 166 | 5 | CID000002820 | |
| Drug | quetiapine | 5.98e-05 | 57 | 166 | 5 | CID000005002 | |
| Drug | tramazoline | 6.02e-05 | 11 | 166 | 3 | CID000005524 | |
| Drug | Trimipramine | 6.02e-05 | 11 | 166 | 3 | DB00726 | |
| Drug | AC1Q6F2A | 6.02e-05 | 11 | 166 | 3 | CID000060621 | |
| Drug | CPG-oligonucleotide | 6.36e-05 | 184 | 166 | 8 | ctd:C408982 | |
| Drug | PBDA | 6.44e-05 | 30 | 166 | 4 | CID000004408 | |
| Drug | CEP-1347 | 7.06e-05 | 59 | 166 | 5 | CID000133005 | |
| Drug | amitriptyline | 7.69e-05 | 140 | 166 | 7 | CID000002160 | |
| Drug | 3-isoreserpine | 7.96e-05 | 190 | 166 | 8 | CID000005052 | |
| Disease | Schizophrenia | DRD2 HTR2A GPS1 NTSR1 NFASC CCND1 CMYA5 CSMD2 GRM3 GRM7 SLC1A6 SEMA3D ADRA2A PBRM1 TENM4 CELF2 ERVK-8 PLA2G6 HCRTR1 | 4.74e-07 | 883 | 163 | 19 | C0036341 |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 6.59e-07 | 4 | 163 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | Obsessive-Compulsive Disorder | 3.27e-06 | 6 | 163 | 3 | C0028768 | |
| Disease | epilepsy (implicated_via_orthology) | 3.57e-05 | 163 | 163 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Major Depressive Disorder | 6.54e-05 | 243 | 163 | 8 | C1269683 | |
| Disease | DNA methylation | DCHS2 DRD2 GALR1 ZPLD1 STC1 GRHL1 TENM4 CELF2 PTPRM MYO3B CACNA1H KIF5A HCRTR1 | 7.72e-05 | 656 | 163 | 13 | GO_0006306 |
| Disease | sensorineural hearing loss (implicated_via_orthology) | 1.50e-04 | 19 | 163 | 3 | DOID:10003 (implicated_via_orthology) | |
| Disease | body mass index, osteoarthritis | 2.29e-04 | 54 | 163 | 4 | EFO_0004340, MONDO_0005178 | |
| Disease | Genomic Instability | 3.00e-04 | 5 | 163 | 2 | C0919532 | |
| Disease | R-6-hydroxywarfarin to R-warfarin ratio measurement | 3.13e-04 | 106 | 163 | 5 | EFO_0803333 | |
| Disease | Mood Disorders | 3.54e-04 | 168 | 163 | 6 | C0525045 | |
| Disease | pancreatic ductal adenocarcinoma (is_marker_for) | 4.39e-04 | 27 | 163 | 3 | DOID:3498 (is_marker_for) | |
| Disease | Asterixis | 4.48e-04 | 6 | 163 | 2 | C0232766 | |
| Disease | Oral Dyskinesia | 4.48e-04 | 6 | 163 | 2 | C0454606 | |
| Disease | Ballismus | 4.48e-04 | 6 | 163 | 2 | C0752196 | |
| Disease | Hemiballismus | 4.48e-04 | 6 | 163 | 2 | C0221169 | |
| Disease | Lingual-Facial-Buccal Dyskinesia | 4.48e-04 | 6 | 163 | 2 | C0152115 | |
| Disease | melanoma | 4.77e-04 | 248 | 163 | 7 | C0025202 | |
| Disease | lymphocyte count | HTR1D GALR1 PCDHGC5 PCDHGB1 PCDHGA11 OLFM4 IQGAP1 SEMA3D PBRM1 TENM4 FBXL18 PPP5C NFATC1 DNAH17 PAPPA PLA2G6 C3 FUT7 SPIC | 4.85e-04 | 1464 | 163 | 19 | EFO_0004587 |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 5.44e-04 | 29 | 163 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | Unipolar Depression | 6.17e-04 | 259 | 163 | 7 | C0041696 | |
| Disease | Involuntary Movements | 6.25e-04 | 7 | 163 | 2 | C0427086 | |
| Disease | Dyskinetic syndrome | 6.25e-04 | 7 | 163 | 2 | C0013384 | |
| Disease | MASA syndrome (implicated_via_orthology) | 6.25e-04 | 7 | 163 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Alcoholic Intoxication, Chronic | 7.54e-04 | 268 | 163 | 7 | C0001973 | |
| Disease | focal segmental glomerulosclerosis (is_marker_for) | 8.31e-04 | 8 | 163 | 2 | DOID:1312 (is_marker_for) | |
| Disease | Urologic Neoplasms | 8.31e-04 | 8 | 163 | 2 | C0042076 | |
| Disease | Cancer of Urinary Tract | 8.31e-04 | 8 | 163 | 2 | C0751571 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 9.51e-04 | 35 | 163 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | Cardiomyopathy, Hypertrophic, Familial | 1.06e-03 | 9 | 163 | 2 | C0949658 | |
| Disease | anterior uveitis (biomarker_via_orthology) | 1.06e-03 | 9 | 163 | 2 | DOID:1407 (biomarker_via_orthology) | |
| Disease | Major depression, single episode | 1.06e-03 | 9 | 163 | 2 | C0024517 | |
| Disease | Depressive disorder | 1.17e-03 | 289 | 163 | 7 | C0011581 | |
| Disease | orofacial cleft, sex interaction measurement | 1.34e-03 | 86 | 163 | 4 | EFO_0008343, MONDO_0000358 | |
| Disease | Bipolar Disorder | 1.40e-03 | 477 | 163 | 9 | C0005586 | |
| Disease | breast carcinoma | CNTNAP1 CCND1 GRM3 GRM7 SPAG6 STC1 INTS10 GRHL1 PTPN9 FDPS NBPF10 NIPAL1 PLA2G6 SPIC | 1.62e-03 | 1019 | 163 | 14 | EFO_0000305 |
| Disease | Lenticulostriate Disorders | 1.93e-03 | 12 | 163 | 2 | C0750951 | |
| Disease | Extrapyramidal Disorders | 1.93e-03 | 12 | 163 | 2 | C0015371 | |
| Disease | amyloid plaque accumulation rate | 1.93e-03 | 12 | 163 | 2 | EFO_0007646 | |
| Disease | Basal Ganglia Diseases | 1.93e-03 | 12 | 163 | 2 | C0004782 | |
| Disease | Endometrioma | 2.05e-03 | 161 | 163 | 5 | C0269102 | |
| Disease | Endometriosis | 2.05e-03 | 161 | 163 | 5 | C0014175 | |
| Disease | Psychotic Disorders | 2.42e-03 | 101 | 163 | 4 | C0033975 | |
| Disease | leprosy | 2.60e-03 | 103 | 163 | 4 | EFO_0001054 | |
| Disease | Saldino-Noonan Syndrome | 2.64e-03 | 14 | 163 | 2 | C0036069 | |
| Disease | C-reactive protein measurement | DCHS2 ZPLD1 VPS13C COQ5 NTSR1 CCDC168 NSUN3 PPP5C CELF1 DNAH17 DOCK7 PLA2G6 EIF3C IL1R1 HCRTR1 | 2.90e-03 | 1206 | 163 | 15 | EFO_0004458 |
| Disease | Mental Depression | 2.96e-03 | 254 | 163 | 6 | C0011570 | |
| Disease | schizophrenia (biomarker_via_orthology) | 3.04e-03 | 15 | 163 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | chenodeoxycholate measurement | 3.04e-03 | 15 | 163 | 2 | EFO_0010471 | |
| Disease | Hypotension | 3.17e-03 | 53 | 163 | 3 | C0020649 | |
| Disease | Rolandic epilepsy | 3.46e-03 | 16 | 163 | 2 | Orphanet_1945 | |
| Disease | trait in response to apixaban | 3.86e-03 | 115 | 163 | 4 | OBA_2050328 | |
| Disease | Kuhnt-Junius degeneration (is_implicated_in) | 3.91e-03 | 17 | 163 | 2 | DOID:10873 (is_implicated_in) | |
| Disease | Child Behaviour Checklist assessment | 4.38e-03 | 18 | 163 | 2 | EFO_0005661 | |
| Disease | Age-related macular degeneration | 4.38e-03 | 18 | 163 | 2 | cv:C0242383 | |
| Disease | Hemangiosarcoma | 4.38e-03 | 18 | 163 | 2 | C0018923 | |
| Disease | COVID-19 (is_marker_for) | 5.16e-03 | 63 | 163 | 3 | DOID:0080600 (is_marker_for) | |
| Disease | heart failure, diabetes mellitus, stroke, atrial fibrillation, mortality, coronary artery disease, cancer | 5.40e-03 | 20 | 163 | 2 | EFO_0000275, EFO_0000400, EFO_0000712, EFO_0001645, EFO_0003144, EFO_0004352, MONDO_0004992 | |
| Disease | seborrheic dermatitis | 5.40e-03 | 20 | 163 | 2 | EFO_1000764 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| ANVIRYFPTQALNFA | 76 | P12236 | |
| QQYAAAALPTLYSQS | 391 | O95319 | |
| VYRNLFIQVDYFPLT | 1151 | P78357 | |
| SLRPRVNYLQDFSYQ | 201 | O71037 | |
| SLRPRVNYLQDFSYQ | 201 | Q902F8 | |
| ERFYRTQAPSYLQQN | 211 | Q93034 | |
| QVPQFLISTSNYLYL | 826 | Q7Z408 | |
| ANSVVNPIVYAYRNR | 281 | P29275 | |
| IQQYAAAALPTLYNQ | 366 | Q92879 | |
| RSSALYFAVVNNNVY | 411 | Q96Q27 | |
| RQFDRYFQSLNPYNN | 331 | Q14832 | |
| PFIVHLYYSLQSANN | 91 | Q96GX5 | |
| TYNSIINPVIYAFRN | 291 | P47775 | |
| PYHAFRFIYISSQLN | 281 | Q9UPC5 | |
| NPLVYTLFNKTYRSA | 376 | P28223 | |
| ANVIRYFPTQALNFA | 76 | P05141 | |
| IRAYYENSPQQVFST | 206 | P01024 | |
| YCNSSLNPVIYTIFN | 416 | P18089 | |
| QLNTYTNFFNNYPVI | 656 | Q008S8 | |
| SYQYILVRNFSLNLT | 56 | B6SEH9 | |
| NLRSPNNFLSYYRLT | 216 | P24385 | |
| STFLQYQGLYPQQAA | 476 | Q6P1W5 | |
| SLNFIRAHTPYINIY | 151 | P11836 | |
| YAKFINTNARTYNEP | 51 | Q8N5S3 | |
| SNPTVFNFYNYLRTH | 1806 | Q9Y485 | |
| TAYAIYQLAVASFPN | 66 | O60397 | |
| IFLAFQQRAYVAPAN | 1601 | Q8IZY2 | |
| AYQHLFYLLQTNPTY | 971 | P46940 | |
| FAPNIYVLNYLNETQ | 986 | P20742 | |
| YQLSPNNYFSLQLRG | 171 | Q9Y5H2 | |
| RTQRAFSIQTPEQYY | 551 | P43378 | |
| TARSLYPADFNIQYE | 31 | Q9NVR2 | |
| LLITNNPYDYAFISQ | 301 | P12883 | |
| PVTSQNVQYFLDRFY | 171 | Q15118 | |
| YPTNQAVIALTFSNY | 131 | Q9UHI5 | |
| IQYSRYTAFSLQDPF | 786 | Q6ZW49 | |
| LQRQAEQNPTASYYN | 721 | O14526 | |
| EQNPTASYYNVVLLR | 726 | O14526 | |
| QHFYLNFTITNLPYS | 14321 | Q8WXI7 | |
| QLTVPNFSNQTAYLY | 406 | Q8WUM0 | |
| NNIENYIISPNSYFR | 166 | Q9Y5F0 | |
| QYAVLLNRFNYPFEL | 51 | Q9H649 | |
| DYINASYIPGNNFRR | 1756 | P23467 | |
| FENAKRYNVPNSAIY | 456 | Q86U86 | |
| RSYQFYAESILNPDA | 281 | Q17RR3 | |
| FYLSSAVNPIIYNLL | 316 | Q9GZQ4 | |
| ALFYVSSTINPILYN | 351 | P30989 | |
| TAQLKLSPYVNYSFR | 706 | Q92823 | |
| AASLYYPQQAIVFAQ | 146 | Q9BUR5 | |
| KQTLENYRTPNFQSY | 1101 | Q6UXM1 | |
| QPYYLNLIELFLQSS | 216 | P14324 | |
| EALQFYLSIPNISYI | 1971 | Q8IYD8 | |
| PNYVQASTYVQRAHL | 376 | Q08397 | |
| SYQYILVRNFSLNLT | 56 | B6SEH8 | |
| LPKNTAYFYSRFNRI | 141 | Q99645 | |
| NELPYLQIASFAYNQ | 131 | Q53EV4 | |
| PPRISQYNLYFNATR | 276 | Q8IZT8 | |
| LYTINPNQYFSLSTK | 166 | Q9Y5G3 | |
| APRFNQQLYTAYILE | 451 | Q9Y5F6 | |
| YTQIRNRALIQYFSP | 366 | Q13098 | |
| NRALIQYFSPYVSAD | 371 | Q13098 | |
| VPTVAQYRFYLSFEN | 216 | Q11130 | |
| PRYANRTSLFYNEIQ | 86 | Q9UM44 | |
| PSYNALRNSEYQRQF | 181 | Q8TC05 | |
| SQYQRFTYLPANVPI | 686 | O95644 | |
| NLAPYTLNFLNIYRN | 776 | P63132 | |
| AAITVLQPFYYLVQQ | 411 | Q6P1A2 | |
| LIIFKNQASRPYNIY | 481 | P00451 | |
| LGRSVSFVYYQQTLQ | 66 | P57087 | |
| AIYTYLQPAQRYNQA | 256 | Q8NGU4 | |
| YNQLSSFRQPKVVRY | 341 | Q13219 | |
| IFSYIQPSSQYFVEQ | 256 | Q8NH18 | |
| PYFTTVFQNSVYRVL | 741 | Q6NUT2 | |
| QSFIQAYATYPRELK | 716 | Q9H8H2 | |
| SYRKAVAQYFPQLLT | 411 | Q5TGP6 | |
| SNVYRNPFAIYLLDV | 51 | Q86SM8 | |
| SLRPRVNYLQDFSYQ | 961 | P63135 | |
| QYSSYNLARFSPVRN | 5366 | Q96RW7 | |
| SFPTYDYFNQVTLQL | 26 | Q8IV76 | |
| FLNSRIQYYIESHNP | 1541 | Q6V1P9 | |
| IQNNLKYPFSIVSYA | 1311 | Q14112 | |
| NSAVLRLSPYVNYQF | 686 | O94856 | |
| LVYANSAANPIIYNF | 346 | O43613 | |
| FNIIASLYDYNPNLA | 376 | Q99613 | |
| LAYSNSSVNPIIYAF | 291 | P47211 | |
| NRNFNPSYAIEVAYV | 381 | Q7L622 | |
| YNNRERIFSLPITNY | 996 | Q9P2D7 | |
| NYLAPYQFLTAFSQL | 2131 | Q13535 | |
| FSLYNPAIVYANQEV | 396 | Q8N6G5 | |
| LPLNIQVDTYSYNNR | 391 | Q9NZI5 | |
| QYDQSLLENLFYTAP | 441 | Q4AC94 | |
| PLYRSNTSQLAFLLY | 81 | O00115 | |
| RNLLYIYPQSLNFAN | 561 | Q96N67 | |
| VFQYLAHTYASRNPN | 221 | P14384 | |
| NYAILRNLQPDTSYT | 1896 | Q99715 | |
| NYLVQAVPFNFYTTS | 2476 | Q9UFH2 | |
| NYLQDFPYQRSLKFR | 96 | P61566 | |
| SLRPRVNYLQDFSYQ | 201 | P61570 | |
| SLRPRVNYLQDFSYQ | 201 | Q69384 | |
| YQLRSQYVSPFPSNS | 401 | Q9NQL9 | |
| YFLNLNSRSPEYLSL | 376 | Q13618 | |
| QPNILFYLNTYSNRS | 861 | A8TX70 | |
| LQPNDNYFFYVRAIN | 3866 | Q8N3K9 | |
| FLALYQTVAVNYSQP | 156 | Q9NZP8 | |
| YLNSLINPIIYTVFN | 346 | P28221 | |
| FRSNPNITFYVYVSN | 1196 | Q5VV63 | |
| SYTSRQIPQNFIADY | 36 | P10147 | |
| SLAFALRPYQLTYRQ | 71 | P48664 | |
| RPYVSYVNNSIARNY | 741 | Q9Y2E5 | |
| NNPLISRLYDLYSFQ | 251 | Q5HYK3 | |
| LRQRQNLDYNYYSVP | 631 | Q08554 | |
| FQNYQNLYLQATPSS | 951 | Q12840 | |
| RYDIFQYQTTNTSNP | 476 | Q14831 | |
| SLRPRVNYLQDFSYQ | 201 | Q902F9 | |
| SVQLSRLCYNYPVIQ | 686 | Q8WYP5 | |
| SNEQRYNYTTPKSFL | 3031 | Q9NYC9 | |
| YVNSAVNPIIYTTFN | 416 | P14416 | |
| LFQRNVLDSFYSYVP | 6056 | Q8NDH2 | |
| LDYFSNRLVNYQISV | 11 | Q15486 | |
| FVRNNNLTFLRPYYQ | 266 | O95180 | |
| LITIFSAPNYLDVYN | 311 | P16298 | |
| YNIQNFDLPYLISRA | 396 | P28340 | |
| DAAYIQLIYPVTNFQ | 321 | P14778 | |
| PEFYQTHFQLAYRLQ | 181 | P42575 | |
| ASPVLYTDLNYSINN | 41 | Q6NVV3 | |
| PIHFQNASLLNSQYY | 646 | P28827 | |
| PEQQNLFYALFLAVY | 21 | Q8WZA6 | |
| RNPYEIQLYLSYQSI | 231 | P26022 | |
| YRPLFFYQETTAQIL | 291 | Q6J4K2 | |
| FPQASASYILLQFAQ | 181 | Q8NFH5 | |
| NNIENYIISPNSYFR | 166 | Q9UN66 | |
| SFIYLRPTANYVSNK | 276 | Q8NGX6 | |
| QTSDQRYVLYPNNFQ | 31 | P06865 | |
| TNYPASRAALVAQNY | 6 | Q9BS40 | |
| SLLFRIVYNQNSVYI | 81 | P59535 | |
| PQLVYSLAEQNRFYK | 86 | O75602 | |
| LAERFYYQALSVAPQ | 196 | Q9UPR3 | |
| NYTIQSFRPYLQEHS | 206 | B4DZS4 | |
| NYTIQSFRPYLQEHS | 111 | Q5H9J9 | |
| QPYRSAFYVLEQQRV | 1386 | Q6P3W6 | |
| QPYRSAFYILEQQCV | 871 | A0A087WUL8 | |
| QPYRSAFYILEQQCV | 2091 | A0A087WUL8 | |
| QPYRSAFYILEQQCV | 3311 | A0A087WUL8 | |
| QPYRSAFYVLEQQRV | 771 | P0DPF2 | |
| QPYRSAFYVLEQQRV | 1991 | P0DPF2 | |
| QPYRSAFYVLEQQRV | 3211 | P0DPF2 | |
| ELNPSNAIYYGNRSL | 56 | P53041 | |
| QSNVPHYQNLRVFYA | 221 | Q96ME1 | |
| RLYPNEFVNYSNAVT | 76 | Q9H156 | |
| LFPSNYVYNRNLKTN | 2266 | Q7Z333 | |
| LQVYENASVLLPAFY | 236 | O15466 | |
| QLFIYIQSISSYLQP | 446 | Q8WWX8 | |
| NAYRTPTFPQFRTQY | 16 | Q9H1Z4 | |
| LVNFHQYSSQLLPFY | 81 | O60733 | |
| NILTDHFQYSRQSYP | 386 | Q96K37 | |
| YQFSEAILQRLSPSY | 191 | Q8N5J4 | |
| TQTLPNAAYNNRFSY | 361 | Q6UX06 | |
| YIQILSSPNFSLDQY | 716 | O95025 | |
| TEVVQLPNHFSNRYY | 146 | P52823 | |
| YCNSSLNPVIYTIFN | 431 | P08913 | |
| ANVIRYFPTQALNFA | 76 | P12235 | |
| TIYVANRFPQNGLYT | 21 | Q9Y2G3 | |
| TFTASFNRPNLYYEV | 276 | P46063 | |
| IATSAYIPLNNYLVF | 331 | Q8TBC4 | |
| YTFNQSRYPRINKES | 186 | Q16851 | |
| NFSFNTYVQLARNYP | 221 | Q96T68 | |
| SYPLEYLVNNTQLAS | 156 | Q8TCW7 | |
| LYGPNFILQVYSSQR | 151 | O15393 | |
| YSNSVLVLDFQSLYP | 2606 | O60673 | |
| QLFDYIQAVSSYLAP | 451 | P31639 | |
| NLLNRLYPNEFVNYT | 91 | O94991 | |
| NFPFYITYIRAHTNL | 556 | P10266 | |
| SLRPRVNYLQDFSYQ | 961 | P10266 | |
| GAFYTLLQDQVRNSY | 1746 | Q6N022 | |
| NYQYIFQPISASAKL | 291 | Q709C8 | |
| FYRYDSLNGVLVSQQ | 111 | A8MT19 | |
| PNAIYLFLVRAANAY | 626 | Q9Y6N7 | |
| RANFYPLQQTNVYTT | 1111 | Q9P283 | |
| YFPQISNATDRKYLV | 91 | O43760 | |
| VCYISNNVQPVLYFL | 101 | Q8TE23 | |
| PFQSVASYYPLQRQL | 461 | Q8TE23 | |
| NVLSNYFPRVSFANQ | 326 | Q9H040 | |
| PQAYLTHFFLRYVNQ | 186 | Q96CP7 | |
| HLLQLPENYNTIFQY | 1746 | Q6ZT12 | |
| AVDSFIYFANIRPNY | 321 | Q9P2L0 | |
| LQLATPALVYQDYQY | 16 | A0A1W2PP97 | |
| AQLRQFYTYTLLPAE | 421 | Q9H1B5 | |
| LTYAEFVQQYAFVRP | 51 | Q96S16 | |
| LLSYPNETNANYISI | 106 | Q9Y3Q0 | |
| FQNLSIYSPQFSRLY | 386 | Q8WXR4 |